Annual report pursuant to Section 13 and 15(d)

Restatement to Previously Issued 2017 Condensed Consolidated Financial Statements (Tables)

v3.8.0.1
Restatement to Previously Issued 2017 Condensed Consolidated Financial Statements (Tables)
12 Months Ended
Dec. 31, 2017
Accounting Changes and Error Corrections [Abstract]  
Restatement To Interim Period Issued Condensed Consolidated Financial Statements

The impact of these changes for the above-mentioned periods are repeated below (in thousands, except share and per share data):

 

March 31, 2017

 

    Three months ended March 31, 2017  
   

As Previously

Reported

    As Restated  
Total other income (expense), net   $ (348 )   $ 1,290  
Total net loss     (2,150 )     (512 )
Deemed dividend related to beneficial conversion feature and accretion of a discount on Series A Preferred Stock     -       -  
Net loss attributable to common stockholders   $ (2,150 )   $ (512 )
Net loss per share attributable to common stockholders:                
Basic and diluted   $ (0.06 )   $ (0.18 )
Weighted average common shares outstanding:                
Basic and diluted     2,826,469       2,826,469  
Common stock, $0.01 par value   $ 30     $ 30  
Additional paid-in capital     231,345       225,432  
Accumulated deficit     (215,285 )     (211,511 )
Total stockholders’ equity   $ 16,090     $ 13,911  
Derivative liabilities, current portion   $ -     $ 2,179